Aurisco Pharmaceutical Co.,Ltd. Financials

Market Capitalization CN¥8.88 Billion as of July 1, 2025

Valuations Metrics as of Jul. 5, 2025

Trailing PE	21.86
Forward PE	17.21
Price to Sales TTM	CN¥5.76
Price to Book MRQ	CN¥3.64
Enterprise to Revenue	5.50
Enterprise to EBITDA	16.21

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-03-31
Profit Margin	25.42%
Operating Margin	35.32%
Return on Assets TTM	8.35%
Return on Equity TTM	17.43%

Income Statement

Revenue TTM	CN¥1,542,113,152
Revenue per Share TTM	CN¥3.90
Quarterly Revenue Growth	19.80%
Gross Profit TTM	CN¥908,342,784
EBITDA	CN¥495,694,107
Net Income to Common TTM	CN¥392,025,536
Diluted EPS TTM	CN¥1.00
Quarterly Earnings Growth YoY	45.30%

Balance Sheet

Total Cash MRQ	CN¥988,025,024
Total Cash per Share MRQ	CN¥2.43
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	39.87
Current Ratio MRQ	4.62
Book Value per Share MRQ	CN¥6.01

Cash Flow

Operating Cash Flow TTM	CN¥268,684,480
Levered Free Cash Flow TTM	CN¥-403,169,408

605116 Stock Info as of Jul. 5, 2025

Stock Statistics

Shares Outstanding	406,195,000
Float Shares	84,391,122
Avg 10 Volume	2,645,717
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	81.62%
% Held by Institutions	2.19%

Stock Price Summary

Beta	-0.16
Fifty Two Week Low	CN¥18.70
Fifty Two Week High	CN¥26.80
Fifty Two Week Change	-14.09%
Day 50 MA	CN¥21.19
Day 200 MA	CN¥21.13

Dividends and Splits

Forward Annual Dividend Rate	CN¥1.16
Forward Annual Dividend Yield	5.31%
Trailing Annual Dividend Rate	CN¥0.29
Trailing Annual Dividend Yield	1.33%
Payout Ratio	22.22%
Dividend Date
Ex Dividend Date	2025-06-20
Last Split Factor
Last Split Date